Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Xiwu Hui, Can Yuan, Weirong Cao, Wenli Ge, Di Zhang, Mo Dan, Qian Zhao, Boning Liu & Bing Yao. (2022) An Innovative Site-Specific Anti-HER2 Antibody-Drug Conjugate with High Homogeneity and Improved Therapeutic Index. OncoTargets and Therapy 15, pages 331-343.
Read now
Read now
Camille Martin, Claire Kizlik-Masson, André Pèlegrin, Hervé Watier, Marie-Claude Viaud-Massuard & Nicolas Joubert. (2018) Antibody-drug conjugates: Design and development for therapy and imaging in and beyond cancer, LabEx MAbImprove industrial workshop, July 27–28, 2017, Tours, France. mAbs 10:2, pages 210-221.
Read now
Read now
Ruth Duncan. (2017) Polymer therapeutics at a crossroads? Finding the path for improved translation in the twenty-first century. Journal of Drug Targeting 25:9-10, pages 759-780.
Read now
Read now
Serengulam V. Govindan, Robert M. Sharkey & David M. Goldenberg. (2016) Prospects and progress of antibody-drug conjugates in solid tumor therapies. Expert Opinion on Biological Therapy 16:7, pages 883-893.
Read now
Read now
Alain Beck, Guillaume Terral, François Debaene, Elsa Wagner-Rousset, Julien Marcoux, Marie-Claire Janin-Bussat, Olivier Colas, Alain Van Dorsselaer & Sarah Cianférani. (2016) Cutting-edge mass spectrometry methods for the multi-level structural characterization of antibody-drug conjugates. Expert Review of Proteomics 13:2, pages 157-183.
Read now
Read now
Articles from other publishers (42)
Florence Ranchon, Étienne Chatelut, Juliette Lambert, Pierre Sesques, Constance Thibault, Isabelle Madelaine, Catherine Rioufol, Véronique Diéras & Jean-Louis Cazin. (2023) Anticorps monoclonaux conjugués et bispécifiques en cancérologie – compte rendu de la Journée de Saint Louis 2022. Bulletin du Cancer 110:12, pages 1343-1351.
Crossref
Crossref
Ya‐Ping Tu, Eva Hanze, Fengying Zhu, H. Maxime Lagraauw, Callum M. Sloss, Michael Method, Brooke Esteves, Eric H. Westin & Anna Berkenblit. (2023)
Population pharmacokinetics of mirvetuximab soravtansine in patients with folate receptor‐
α
positive ovarian cancer: The antibody–drug conjugate, payload and metabolite
. British Journal of Clinical Pharmacology.
Crossref
Crossref
Adrian D. Hobson, Jianwen Xu, Dennie S. Welch, Christopher C. Marvin, Michael J. McPherson, Bradley Gates, Xiaoli Liao, Markus Hollmann, Michael J. Gattner, Kristina Dzeyk, Hetal Sarvaiya, Vikram M. Shenoy, Margaret M. Fettis, Agnieszka K. Bischoff, Lu Wang, Ling C. Santora, Lu Wang, Julia Fitzgibbons, Paulin Salomon, Axel HernandezJr.Jr., Ying Jia, Christian A. Goess, Suzanne L. Mathieu, Shaughn H. Bryant, Mary E. Larsen, Baoliang Cui & Yu Tian. (2023) Discovery of ABBV-154, an anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody-Drug Conjugate (iADC). Journal of Medicinal Chemistry 66:17, pages 12544-12558.
Crossref
Crossref
Feng Yin, Diana Adhikari, Marlking Peay, Diego Cortes, Mohammed Garada, M. Shane Woolf, Eric Ma, Diane Lebarbenchon, William Mylott, Mike Dyszel, Shawn Harriman & Jan Pinkas. (2023) Development and validation of a hybrid immunoaffinity LC–MS/MS assay for quantitation of total antibody (TAb) from an antibody drug conjugate (ADC) PYX-201 in human plasma. Journal of Chromatography B 1228, pages 123844.
Crossref
Crossref
Adrian D. Hobson, Jianwen Xu, Christopher C. Marvin, Michael J. McPherson, Markus Hollmann, Michael Gattner, Kristina Dzeyk, Margaret M. Fettis, Agnieszka K. Bischoff, Lu Wang, Julia Fitzgibbons, Lu Wang, Paulin Salomon, Axel HernandezJr.Jr., Ying Jia, Hetal Sarvaiya, Christian A. Goess, Suzanne L. Mathieu & Ling C. Santora. (2023) Optimization of Drug-Linker to Enable Long-term Storage of Antibody–Drug Conjugate for Subcutaneous Dosing. Journal of Medicinal Chemistry 66:13, pages 9161-9173.
Crossref
Crossref
Heejin Park. (2022) The Simplest Pharmacokinetic Equation in ADC (Antibody Drug Conjugate) or PDC (Peptide Drug Conjugate) Research. International Journal of Advanced Pharmaceutical Sciences and Research 2:5, pages 1-4.
Crossref
Crossref
Iftekhar Mahmood. (2022) A Simple Method for the Prediction of Human Concentration–Time Profiles and Pharmacokinetics of Antibody–Drug Conjugates (ADC) from Rats or Monkeys. Antibodies 11:2, pages 42.
Crossref
Crossref
Nawid Albinger, Rita Pfeifer, Marcus Nitsche, Sarah Mertlitz, Julia Campe, Katja Stein, Hermann Kreyenberg, Ralf Schubert, Melissa Quadflieg, Dina Schneider, Michael W. M. Kühn, Olaf Penack, Congcong Zhang, Nina Möker & Evelyn Ullrich. (2022) Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia. Blood Cancer Journal 12:4.
Crossref
Crossref
Robert S. Foti. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
716
742
.
Iftekhar Mahmood. (2021) Effect of Intrinsic and Extrinsic Factors on the Pharmacokinetics of Antibody–Drug Conjugates (ADCs). Antibodies 10:4, pages 40.
Crossref
Crossref
Manar Hammood, Andrew Craig & Jeffrey Leyton. (2021) Impact of Endocytosis Mechanisms for the Receptors Targeted by the Currently Approved Antibody-Drug Conjugates (ADCs)—A Necessity for Future ADC Research and Development. Pharmaceuticals 14:7, pages 674.
Crossref
Crossref
Iftekhar Mahmood. (2021) Clinical Pharmacology of Antibody-Drug Conjugates. Antibodies 10:2, pages 20.
Crossref
Crossref
Charlotte Lemech, Natasha Woodward, Nancy Chan, Joanne Mortimer, Louie Naumovski, Silpa Nuthalapati, Bo Tong, Fang Jiang, Peter Ansell, Christine K. Ratajczak & Jasgit Sachdev. (2020) A first-in-human, phase 1, dose-escalation study of ABBV-176, an antibody-drug conjugate targeting the prolactin receptor, in patients with advanced solid tumors. Investigational New Drugs 38:6, pages 1815-1825.
Crossref
Crossref
Gordon Minru Xiong, Kailash Venkatraman & Subbu Venkatraman. (2020) The magic bullet as cancer therapeutic—has nanotechnology failed to find its mark?. Progress in Biomedical Engineering 2:4, pages 042004.
Crossref
Crossref
Peiying Zuo. (2020) Capturing the Magic Bullet: Pharmacokinetic Principles and Modeling of Antibody-Drug Conjugates. The AAPS Journal 22:5.
Crossref
Crossref
Clément Bailly, Benjamin Chalopin, Sébastien Gouard, Thomas Carlier, Patricia Remaud-Le Saëc, Séverine Marionneau-Lambot, Philippe Moreau, Cyrille Touzeau, Françoise Kraeber-Bodere, Caroline Bodet-Milin & Michel Chérel. (2020) ImmunoPET in Multiple Myeloma—What? So What? Now What?. Cancers 12:6, pages 1467.
Crossref
Crossref
Valentina Boni, Manish R. Sharma & Amita Patnaik. (2020) The Resurgence of Antibody Drug Conjugates in Cancer Therapeutics: Novel Targets and Payloads. American Society of Clinical Oncology Educational Book:40, pages e58-e74.
Crossref
Crossref
Colby S. Shemesh, Priya Agarwal, Tong Lu, Calvin Lee, Randall C. Dere, Xiaobin Li, Chunze Li, Jin Y. Jin, Sandhya Girish, Dale Miles & Dan Lu. (2020) Pharmacokinetics of polatuzumab vedotin in combination with R/G-CHP in patients with B-cell non-Hodgkin lymphoma. Cancer Chemotherapy and Pharmacology 85:5, pages 831-842.
Crossref
Crossref
Gareth D. Healey, Belen Pan-Castillo, Jezabel Garcia-Parra, Julia Davies, Shaun Roberts, Eilir Jones, Kalyan Dhar, Sarika Nandanan, Nasima Tofazzal, Luke Piggott, Richard Clarkson, Gillian Seaton, Asa Frostell, Tim Fagge, Colin McKee, Lavinia Margarit, R. Steven Conlan & Deyarina Gonzalez. (2019) Antibody drug conjugates against the receptor for advanced glycation end products (RAGE), a novel therapeutic target in endometrial cancer. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Crossref
Steven Coats, Marna Williams, Benjamin Kebble, Rakesh Dixit, Leo Tseng, Nai-Shun Yao, David A. Tice & Jean-Charles Soria. (2019) Antibody–Drug Conjugates: Future Directions in Clinical and Translational Strategies to Improve the Therapeutic Index. Clinical Cancer Research 25:18, pages 5441-5448.
Crossref
Crossref
Wayne C. Widdison. 2019. Cytotoxic Payloads for Antibody – Drug Conjugates. Cytotoxic Payloads for Antibody – Drug Conjugates
100
116
.
Brandon Bumbaca, Zhe Li & Dhaval K. Shah. (2019) Pharmacokinetics of protein and peptide conjugates. Drug Metabolism and Pharmacokinetics 34:1, pages 42-54.
Crossref
Crossref
Andrew T. Lucas, Ryan Robinson, Allison N. Schorzman, Joseph A. Piscitelli, Juan F. Razo & William C. Zamboni. (2019) Pharmacologic Considerations in the Disposition of Antibodies and Antibody-Drug Conjugates in Preclinical Models and in Patients. Antibodies 8:1, pages 3.
Crossref
Crossref
Yukinori Endo, Kazuyo Takeda, Nishant Mohan, Yi Shen, Jiangsong Jiang, David Rotstein & Wen Jin Wu. (2018) Payload of T-DM1 binds to cell surface cytoskeleton-associated protein 5 to mediate cytotoxicity of hepatocytes. Oncotarget 9:98, pages 37200-37215.
Crossref
Crossref
Si Mou, Yue Huang & Anton Rosenbaum. (2018) ADME Considerations and Bioanalytical Strategies for Pharmacokinetic Assessments of Antibody-Drug Conjugates. Antibodies 7:4, pages 41.
Crossref
Crossref
Amita Datta-Mannan, Hiuwan Choi, David Stokell, Jason Tang, Anthony Murphy, Aaron Wrobleski & Yiqing Feng. (2018) The Properties of Cysteine-Conjugated Antibody-Drug Conjugates Are Impacted by the IgG Subclass. The AAPS Journal 20:6.
Crossref
Crossref
Eshita Khera & Greg M. Thurber. (2018) Pharmacokinetic and Immunological Considerations for Expanding the Therapeutic Window of Next-Generation Antibody–Drug Conjugates. BioDrugs 32:5, pages 465-480.
Crossref
Crossref
Vera Luginbuehl, Nicolas Meier, Karin Kovar & Jack Rohrer. (2018) Intracellular drug delivery: Potential usefulness of engineered Shiga toxin subunit B for targeted cancer therapy. Biotechnology Advances 36:3, pages 613-623.
Crossref
Crossref
Laura Sánchez-García, Naroa Serna, Patricia Álamo, Rita Sala, María Virtudes Céspedes, Mònica Roldan, Alejandro Sánchez-Chardi, Ugutz Unzueta, Isolda Casanova, Ramón Mangues, Esther Vázquez & Antonio Villaverde. (2018) Self-assembling toxin-based nanoparticles as self-delivered antitumoral drugs. Journal of Controlled Release 274, pages 81-92.
Crossref
Crossref
Paul Malik, Colin Phipps, Andrea Edginton & Jonathan Blay. (2017) Pharmacokinetic Considerations for Antibody-Drug Conjugates against Cancer. Pharmaceutical Research 34:12, pages 2579-2595.
Crossref
Crossref
Bernadette V. Marquez-Nostra, Supum Lee, Richard Laforest, Laura Vitale, Xingyu Nie, Krzysztof Hyrc, Tibor Keler, Thomas Hawthorne, Jeremy Hoog, Shunqiang Li, Farrokh Dehdashti, Cynthia X. Ma & Suzanne E. Lapi. (2017) Preclinical PET imaging of glycoprotein non-metastatic melanoma B in triple negative breast cancer: feasibility of an antibody-based companion diagnostic agent. Oncotarget 8:61, pages 104303-104314.
Crossref
Crossref
Mary Jane Masson Hinrichs, Pauline M. Ryan, Bo Zheng, Shameen Afif-Rider, Xiang Qing Yu, Michele Gunsior, Haihong Zhong, Jay Harper, Binyam Bezabeh, Kapil Vashisht, Marlon Rebelatto, Molly Reed, Patricia C. Ryan, Shannon Breen, Neki Patel, Cui Chen, Luke Masterson, Arnaud Tiberghien, Phillip W. Howard, Nazzareno Dimasi & Rakesh Dixit. (2017) Fractionated Dosing Improves Preclinical Therapeutic Index of Pyrrolobenzodiazepine-Containing Antibody Drug Conjugates. Clinical Cancer Research 23:19, pages 5858-5868.
Crossref
Crossref
Heather E. Vezina, Monette Cotreau, Tae H. Han & Manish Gupta. (2017) Antibody-Drug Conjugates as Cancer Therapeutics: Past, Present, and Future. The Journal of Clinical Pharmacology 57, pages S11-S25.
Crossref
Crossref
Marion Bouillon-Pichault, Claire Brillac, Céline Amara, Céline Nicolazzi, Nathalie Fagniez, Jean-Baptiste Fau, Kimiko Koiwai, Samira Ziti-Ljajic & Christine Veyrat-Follet. (2017) Translational Model-Based Strategy to Guide the Choice of Clinical Doses for Antibody-Drug Conjugates. The Journal of Clinical Pharmacology 57:7, pages 865-875.
Crossref
Crossref
Amrita V. Kamath. 2016. Antibody‐Drug Conjugates. Antibody‐Drug Conjugates
245
266
.
M. Walles, B. Rudolph, T. Wolf, J. Bourgailh, M. Suetterlin, T. Moenius, G. Peraus, O. Heudi, W. Elbast, C. Lanshoeft & S. Bilic. (2016) New Insights in Tissue Distribution, Metabolism, and Excretion of [3H]-Labeled Antibody Maytansinoid Conjugates in Female Tumor-Bearing Nude Rats. Drug Metabolism and Disposition 44:7, pages 897-910.
Crossref
Crossref
E. Kraynov, A. V. Kamath, M. Walles, E. Tarcsa, A. Deslandes, R. A. Iyer, A. Datta-Mannan, P. Sriraman, M. Bairlein, J. J. Yang, M. Barfield, G. Xiao, E. Escandon, W. Wang, D. A. Rock, N. V. Chemuturi & D. J. Moore. (2015) Current Approaches for Absorption, Distribution, Metabolism, and Excretion Characterization of Antibody-Drug Conjugates: An Industry White Paper. Drug Metabolism and Disposition 44:5, pages 617-623.
Crossref
Crossref
Amrita V. Kamath & Suhasini Iyer. (2015) Challenges and advances in the assessment of the disposition of antibody‐drug conjugates. Biopharmaceutics & Drug Disposition 37:2, pages 66-74.
Crossref
Crossref
Peng Zou, Sau Lee, Min Li, Lawrence Yu & Duxin Sun. 2016. Pharmacokinetics in Drug Development. Pharmacokinetics in Drug Development
39
58
.
Guy M.L. Meno‐Tetang. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
12
.
Chetan Rathi & Bernd Meibohm. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
16
.
Mary Jane Masson Hinrichs & Rakesh Dixit. (2015) Antibody Drug Conjugates: Nonclinical Safety Considerations. The AAPS Journal 17:5, pages 1055-1064.
Crossref
Crossref